In vitro bromodeoxyuridine labeling of rat bone marrow-derived mesenchymal stem cells

Abstract

Abstract: Objective To study the optimal dosage and timing for bromodeoxyuridine(BrdU) labeling of rat bone marrow-derived mesenchymal stem cells(MSCs) in vitro. Methods Bone marrow-derived MSCs of SD rats were cultured in vitro routinely and the sixth passage was taken for identification of specific surface antigens by flow cytometry. Before reaching cell confluence, the purified MSCs were incubated with BrdU at different concentrations(5, 10, and 15 μmol/L) for different incubating time(3, 12, 24, 36, 48, and 72 h) with 10 μmol/L BrdU, to identify the optimal BrdU concentration and incubating time for cell labeling. Immunohistochemistry was performed to calculate the labeling index(LI). Result Flow cytometry showed that MSCs expressed CD29 and CD44 but not CD11b or CD45. Incubation of the MSCs with BrdU at 10 μmol/L and for an optimal length of 48 h appeared to achieve the highest LI, both of which exceeded 98%, with the labeling identifiable in five consecutive passages. Conclusions The continually passaged cells are MSCs, the incubation of which with 10 μmol/L BrdU for 48 h may achieve a LI over 98% without producing obvious cell damages. The results suggest that BrdU labeling provides a feasible means for a dynamic in vivo observation of the survival, growth and differentiation of the implanted MSCs.

CLC Number:

R329.24

FENG Shan-wei, YAO Xiao-li, LI Zhong, LIU Tai-yun, HUANG Wen, ZHANG Cheng. In vitro bromodeoxyuridine labeling of rat bone marrow-derived mesenchymal stem cells[J]. Journal of Southern Medical University, 2005, 25(02): 184-186.

References

[1] Pittenger MF, Mackay AM, Jaiswal SC, et al. Multilineage potential of adult human mesenchymal stem cells [J]. Science, 1999, 284(5411): 143-7.
[2] Pereira RF, Halford KW, O’Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice[J]. Proc Natl Acad Sci USA,1995, 92(11): 4857-61.
[3] Kadiyala S, Young RG, Thiede MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro[J]. Cell Transplant, 1997, 6(2): 125-34.
[4] Richards M, Huibregtse BA, Caplan AI, et al. Marrow-derived progenitor cell injections enhance new bone formation during distraction [J]. J Orthop Res, 1999, 17(6): 900-8.
[5] Sekiya I, Vuoristo JT, Larson BL, et al. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis [J]. Proc Natl Acad Sci USA, 2002, 99(7): 4397-402.
[6] Dennis JE, Merriam A, Awadallah A, et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse[J]. J Bone Miner Res, 1999, 14(5): 700-9.
[7] Munoz-Elias G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions [J]. Stem Cells, 2003, 21(4): 437-48.
[8] Ferrari G, Cusella-de Angelis G, Coletta M, et al. Muscle regenera tion by bone marrow-derived myogenic progenitors [J]. Science, 1998, 279(5356): 1528-30.
[9] LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury[J]. Cell, 2002, 111(4): 589-601.
[10] Gratzner HG. Monoclonal antibody to 5-bromo and 5-iodo-deoxyu ridine: a new reagent for detection of DNA replication[J]. Science, 1982, 218(4571): 474-5.
[11] Nakamura S, Takeda Y, Kanno M, et al. Application of bromodeoxyuridine(BrdU) and anti-BrdU monoclonal antibody for the in vivo analysis of prolifrative characteristics of human leukemia cells in bone marrow[J]. Oncology, 1991, 48(4): 285-9.